SCHEMBL20047565

SCHEMBL20047565

CCCCCCCC(C)(C)CCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.58
PPARG P37231 7/20 0.58
PPARD Q03181 7/20 0.58
PPARA Q07869 7/20 0.58
HDAC11 Q96DB2 5/20 0.58
TSHR P16473 4/20 0.58
PTPN1 P18031 3/20 0.58
TDP1 Q9NUW8 3/20 0.58
ALDH1A1 P00352 2/20 0.58
TLR2 O60603 2/20 0.58
FABP4 P15090 2/20 0.58
FFAR1 O14842 2/20 0.58
KMT2A Q03164 2/20 0.58
SLC22A6 Q4U2R8 1/20 0.58
SLC22A8 Q8TCC7 1/20 0.58
MEN1 O00255 1/20 0.58
ESR1 P03372 1/20 0.58
ALOX15 P16050 1/20 0.58
PDE4A P27815 1/20 0.58
PDE3A Q14432 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116131 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL27542360 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1116137 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7864001 1.00 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL20820000 0.98 AKR1B1 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5878877 0.92 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861428 0.92 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861306 0.92 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28415946 0.92 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8039123 0.92 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof GPBAR1, SLC10A1, NR1H4 GPR84 124/4885PPARG 29/4885PPARD 139/4885
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF GPBAR1, SLC10A1, NR1H4 GPR84 124/4885PPARG 29/4885PPARD 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.